Human and mouse proteomics reveals the shared pathways in Alzheimer’s disease and delayed protein turnover in the amyloidome
Top Cited Papers
Open Access
- 11 February 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Abstract
Murine models of Alzheimer’s disease (AD) are crucial for elucidating disease mechanisms but have limitations in fully representing AD molecular complexities. Here we present the comprehensive, age-dependent brain proteome and phosphoproteome across multiple mouse models of amyloidosis. We identified shared pathways by integrating with human metadata and prioritized components by multi-omics analysis. Collectively, two commonly used models (5xFAD and APP-KI) replicate 30% of the human protein alterations; additional genetic incorporation of tau and splicing pathologies increases this similarity to 42%. We dissected the proteome-transcriptome inconsistency in AD and 5xFAD mouse brains, revealing that inconsistent proteins are enriched within amyloid plaque microenvironment (amyloidome). Our analysis of the 5xFAD proteome turnover demonstrates that amyloid formation delays the degradation of amyloidome components, including Aβ-binding proteins and autophagy/lysosomal proteins. Our proteomic strategy defines shared AD pathways, identifies potential targets, and underscores that protein turnover contributes to proteome-transcriptome discrepancies during AD progression.Keywords
All Related Versions
Funding Information
- ALSAC
This publication has 128 references indexed in Scilit:
- The importance of continuing development of novel animal models of Alzheimer's disease and Alzheimer's disease and related dementiasAlzheimer's & Dementia, 2024
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brainsActa Neuropathologica, 2023
- PANTHER: Making genome‐scale phylogenetics accessible to allProtein Science, 2021
- Alzheimer’s disease: experimental models and realityActa Neuropathologica, 2016
- Quantitative Protein Analysis by Mass Spectrometry2015
- Quantitative phosphoproteomics of Alzheimer's disease reveals cross‐talk between kinases and small heat shock proteinsProteomics, 2014
- Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteomeProteomics, 2014
- Synaptic degeneration in Alzheimer’s diseaseActa Neuropathologica, 2009
- Lysosomal Membrane Damage in Soluble Aβ-Mediated Cell Death in Alzheimer's DiseaseNeurobiology of Disease, 2001